| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740733 | Journal of Infection and Chemotherapy | 2018 | 7 Pages |
Abstract
The superior effect of bezlotoxumab 10 mg/kg in the prevention of recurrent C. difficile infection suggests that the agent will be useful in the rapidly aging Japanese society.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Hiroshige Mikamo, Norihiro Aoyama, Miyuki Sawata, Go Fujimoto, Mary Beth Dorr, Tomoko Yoshinari,